Are you a start-up or outside the US(OUS) companies coming to the US for the first time? We are commercialization experts uniting the business and technical. We have helped  250+ life science companies to successfully bring their technologies to market. From our experience:

• Most companies are undercapitalized
  • They do not have the funding nor the velocity to successfully commercialize.
• Many are focused on the technical and do not have a comprehensive commercialization plan.
  • Commercialization areas are interconnected, need to be defined early to obtain funding, and are vital to success. Funders and acquirers want to minimize risk across clinical, regulatory, reimbursement, target market attractiveness, intellectual property, funding, sales and marketing, features to needs, and management team
• Often companies do not truly understand what their customers want, how they purchase, how the technology fits into workflows, and the value across all stakeholders seek.
  • The purchase decision in life science is complicated–with so many stakeholders: physicians, administrators, patients, payers, and others,

From commercialization plans, to grant applications, to market opportunity assessment and validation to market access, clinical, and reimbursement strategies and execution, we are the Experts to the Experts (You!). Let us help you get to market quicker, on-target, with less cost. Our work will lead you to more funding, revenue sooner, growing revenue, and maximizing profitability. Clients include Glimpse Diagnostics, Amygdala Neurosciences, Neurocarrus, Camellix, Fluidispec, Champaign Imaging, Exias Medical, Cognition Corporation. Our collaborations with the National Institute of Health (NIH), the MN Cup, Medical Alley (MN), AZBio, the Bullpen Club, AZ Angels and more. Reach out today to see how m.zoro, a woman majority owned business, can help you.